Variant report
Variant | nsv608291 |
---|---|
Chromosome Location | chr7:118832226-118850537 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs551235197 | chr7:118835828-118835829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs58579703 | chr7:118835838-118835839 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs191034578 | chr7:118835858-118835859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs572677448 | chr7:118835890-118835891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs182601294 | chr7:118835957-118835958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs558128417 | chr7:118836088-118836089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs530484585 | chr7:118836141-118836142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs576911858 | chr7:118836171-118836172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs79070005 | chr7:118836193-118836194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562614079 | chr7:118836219-118836220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs139018895 | chr7:118836279-118836280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541689207 | chr7:118836300-118836301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561943093 | chr7:118836389-118836390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs149238161 | chr7:118836444-118836445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs547677771 | chr7:118836493-118836494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374759170 | chr7:118836632-118836633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563990035 | chr7:118836638-118836639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550568719 | chr7:118836676-118836677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs566896298 | chr7:118836693-118836694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536170855 | chr7:118836707-118836708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552830524 | chr7:118836724-118836725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs566367862 | chr7:118836803-118836804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs369055129 | chr7:118836837-118836838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs187343588 | chr7:118836873-118836874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549755115 | chr7:118836876-118836877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs144451225 | chr7:118836909-118836910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535921231 | chr7:118836944-118836945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs549179882 | chr7:118836966-118836967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs566273245 | chr7:118836975-118836976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534860907 | chr7:118836977-118836978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs56015007 | chr7:118836991-118836992 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs571961256 | chr7:118836992-118836993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs558418033 | chr7:118837005-118837006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs148425382 | chr7:118837063-118837064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs10232674 | chr7:118837183-118837184 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs207468476 | chr7:118837294-118837295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs575921505 | chr7:118837328-118837329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs575703058 | chr7:118837377-118837378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs372609550 | chr7:118837465-118837466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs541927047 | chr7:118837542-118837543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs141697746 | chr7:118837661-118837662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555127219 | chr7:118837692-118837693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs572207087 | chr7:118837703-118837704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs147191998 | chr7:118837817-118837818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs78085409 | chr7:118837826-118837827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140464116 | chr7:118837858-118837859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs543438275 | chr7:118837914-118837915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs563362861 | chr7:118837942-118837943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs144412348 | chr7:118837955-118837956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552897791 | chr7:118838007-118838008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Schizophrenia | 21346763 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:118835800-118836800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr7:118836600-118837000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr7:118836600-118838000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr7:118836600-118838200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr7:118837200-118838000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr7:118837200-118838000 | Enhancers | HMEC | breast |
7 | chr7:118837200-118838200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr7:118837400-118838000 | Enhancers | NHEK | skin |
9 | chr7:118837800-118838200 | Enhancers | Dnd41 | blood |
10 | chr7:118838000-118838400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr7:118838400-118839600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
12 | chr7:118839600-118839800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr7:118839800-118840200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
14 | chr7:118840200-118840800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
15 | chr7:118840200-118841200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
16 | chr7:118840400-118841200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
17 | chr7:118840600-118841200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
18 | chr7:118840600-118841400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
19 | chr7:118841000-118841400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |